RA 27/3 (humandiploid fibroblast) strain of rubella vaccine
Trade name: Meruvax II
Vaccineapproved
Approved
Jul 1, 1979
Clinical trial activity
0 trials · 0 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
0
Timeline
1970s
- Jul 1, 1979
Earliest FDA Approval
Indications
Approved for
Mechanism of action
- Rubella virusImmunity, active
Rubella virus immunity, active
Approval history
- approvedJul 1, 1979
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No